AIG
LPCN icon

American International Group’s Lipocine LPCN Stock Holding History

American International Group’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-600
Closed -$40K – 3101
2017
Q1 		$40K Buy
600
+40
+7% +$2.59K ﹤0.01% 2884
2016
Q4 		$35K Sell
560
-2
-0.4% -$127 ﹤0.01% 2916
2016
Q3 		$42.6K Buy
562
+1
+0.2% +$62 ﹤0.01% 2928
2016
Q2 		$29K Buy
+561
New +$86.9K ﹤0.01% 3031

Other funds holding LPCN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American International Group's LPCN Position: Q2 2017 in Review

American International Group sold out of Lipocine (LPCN) in Q2 2017, closing a stake of 600 shares — an estimated $40K sold.

American International Group first reported a position in LPCN in Q2 2016 and held it in 4 quarters. The position peaked at $42.6K in Q3 2016. 42 funds tracked by Wall St. Rank hold LPCN as of Q2 2017.

  • American International Group reported no remaining Lipocine position as of Q2 2017 after selling out during the quarter.
  • American International Group sold 600 Lipocine shares in Q2 2017, an estimated $40K.
  • American International Group first reported a position in Lipocine in Q2 2016 and held it in 4 quarters.
  • American International Group's Lipocine position peaked at $42.6K in Q3 2016.
  • 42 funds tracked by Wall St. Rank held Lipocine as of Q2 2017.

Based on American International Group's 13F filing for Q2 2017, filed 11 Aug 2017.